FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example MedicationDispense/meddisp0306 (Narrative)

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationDispense.


Generated Narrative: MedicationDispense

Resource MedicationDispense "meddisp0306"

status: in-progress

Medications

-Reference
*

code: alemtuzumab 10 MG/ML [Lemtrada] (RxNorm#1594660)

subject: Patient/pat1: Donald Duck "Donald DUCK"

Performers

-Actor
*Practitioner/f006 "Rob VAN DEN BERK"

authorizingPrescription: MedicationRequest/medrx0317

type: Daily Fill (ActCode#DF)

quantity: 5(unit 415818006 from http://snomed.info/sct) (Details: SNOMED CT code 415818006 = 'Vial')

daysSupply: 7 Day (Details: UCUM code d = 'd')

whenPrepared: 2015-01-15T10:20:00Z

dosageInstruction

sequence: 1

text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction: Rapidly increase dose until tolerated (), Administer on alternate days ()

timing: Duration 12weeks, 3 per 1 weeks

route: Intravenous route (SNOMED CT#47625008)

method: Inject - dosing instruction imperative (qualifier value) (SNOMED CT#422145002)

doseAndRate

dosageInstruction

sequence: 2

text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction: Rapidly increase dose until tolerated (), Administer on alternate days ()

timing: Duration 12weeks, 3 per 1 weeks

route: Intravenous route (SNOMED CT#47625008)

method: Inject - dosing instruction imperative (qualifier value) (SNOMED CT#422145002)

doseAndRate

dosageInstruction

sequence: 3

text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction: Rapidly increase dose until tolerated (), Administer on alternate days ()

timing: Duration 12weeks, 3 per 1 weeks

route: Intravenous route (SNOMED CT#47625008)

method: Inject - dosing instruction imperative (qualifier value) (SNOMED CT#422145002)

doseAndRate


Generated Narrative: Medication #med0303

code: alemtuzumab 10 MG/ML [Lemtrada] (RxNorm#1594660)


 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.